{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:07:43Z","timestamp":1787314063110,"version":"build-2736575974"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","atherosclerosis-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.atherosclerosis.2018.01.022","type":"journal-article","created":{"date-parts":[[2018,1,16]],"date-time":"2018-01-16T21:16:46Z","timestamp":1516137406000},"page":"1-7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"special_numbering":"C","title":["Cardiovascular disease in systemic lupus erythematosus is associated with increased levels of biomarkers reflecting receptor-activated apoptosis"],"prefix":"10.1016","volume":"270","author":[{"given":"Maria","family":"Wigren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabet","family":"Svenungsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid Yao","family":"Mattisson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna T.","family":"Gustafsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iva","family":"Gunnarsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agneta","family":"Zickert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Elvin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Jensen-Urstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Bengtsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgitta","family":"Gullstrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunilla Nordin","family":"Fredrikson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9752-7479","authenticated-orcid":false,"given":"Jan","family":"Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2018.01.022_bib1","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1161\/CIRCULATIONAHA.113.007603","article-title":"Time-dependent changes in atherosclerotic plaque composition in patients undergoing carotid surgery","volume":"129","author":"van Lammeren","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2018.01.022_bib2","first-page":"2984","article-title":"Requiem for the 'vulnerable plaque'","volume":"36","author":"Libby","year":"2015","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2018.01.022_bib3","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1093\/eurheartj\/ehx143","article-title":"Atherosclerotic plaque vulnerability in the statin era","volume":"38","author":"Nilsson","year":"2017","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2018.01.022_bib4","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/ni.2001","article-title":"The immune system in atherosclerosis","volume":"12","author":"Hansson","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.atherosclerosis.2018.01.022_bib5","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1172\/JCI63108","article-title":"Adaptive immunity in atherogenesis: new insights and therapeutic approaches","volume":"123","author":"Lichtman","year":"2013","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.atherosclerosis.2018.01.022_bib6","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/joim.12353","article-title":"Atheroprotective immunity and cardiovascular disease: therapeutic opportunities and challenges","volume":"278","author":"Nilsson","year":"2015","journal-title":"J.\u00a0Intern. Med."},{"key":"10.1016\/j.atherosclerosis.2018.01.022_bib7","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1538-7836.2006.01753.x","article-title":"International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS)","volume":"4","author":"Miyakis","year":"2006","journal-title":"J.\u00a0Thromb. Haemostasis"},{"key":"10.1016\/j.atherosclerosis.2018.01.022_bib8","doi-asserted-by":"crossref","first-page":"379","DOI":"10.14740\/jocmr2122w","article-title":"The increased cardiovascular risk in patients affected by autoimmune diseases: review of the various manifestations","volume":"7","author":"Durante","year":"2015","journal-title":"J.\u00a0Clin. Med. Res."},{"key":"10.1016\/j.atherosclerosis.2018.01.022_bib9","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1002\/1529-0131(200110)44:10<2331::AID-ART395>3.0.CO;2-I","article-title":"Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus","volume":"44","author":"Esdaile","year":"2001","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.atherosclerosis.2018.01.022_bib10","first-page":"2363","article-title":"Contribution of traditional risk factors to coronary artery disease in patients with systemic lupus erythematosus","volume":"26","author":"Rahman","year":"1999","journal-title":"J.\u00a0Rheumatol."},{"key":"10.1016\/j.atherosclerosis.2018.01.022_bib11","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1056\/NEJMra1100359","article-title":"Systemic lupus erythematosus","volume":"365","author":"Tsokos","year":"2011","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2018.01.022_bib12","doi-asserted-by":"crossref","first-page":"36025","DOI":"10.1038\/srep36025","article-title":"Microparticles in the blood of patients with systemic lupus erythematosus (SLE): phenotypic characterization and clinical associations","volume":"6","author":"Mobarrez","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.atherosclerosis.2018.01.022_bib13","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1161\/ATVBAHA.111.224873","article-title":"Apoptotic cell death and efferocytosis in atherosclerosis","volume":"32","author":"Van Vre","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2018.01.022_bib14","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/art.1780251101","article-title":"The 1982 revised criteria for the classification of systemic lupus erythematosus","volume":"25","author":"Tan","year":"1982","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.atherosclerosis.2018.01.022_bib15","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/cei.12651","article-title":"Decreased levels of autoantibodies against apolipoprotein B-100 antigens are associated with cardiovascular disease in systemic lupus erythematosus","volume":"181","author":"Svenungsson","year":"2015","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.atherosclerosis.2018.01.022_bib16","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1002\/art.1780390303","article-title":"The development and initial validation of the Systemic Lupus International Collaborating Clinics\/American College of Rheumatology damage index for systemic lupus erythematosus","volume":"39","author":"Gladman","year":"1996","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.atherosclerosis.2018.01.022_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0174572","article-title":"Excess atherosclerosis in systemic lupus erythematosus,-A matter of renal involvement: case control study of 281 SLE patients and 281 individually matched population controls","volume":"12","author":"Gustafsson","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.atherosclerosis.2018.01.022_bib18","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1161\/01.ATV.0000067935.02679.B0","article-title":"Identification of immune responses against aldehyde-modified peptide sequences in apo B-100 associated with cardiovascular disease","volume":"23","author":"Fredrikson","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2018.01.022_bib19","doi-asserted-by":"crossref","first-page":"e188","DOI":"10.1016\/j.atherosclerosis.2006.12.014","article-title":"Autoantibody against the amino acid sequence 661-680 in apo B-100 is associated with decreased carotid stenosis and cardiovascular events","volume":"194","author":"Fredrikson","year":"2007","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2018.01.022_bib20","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ebiom.2017.11.023","article-title":"Elevated markers of death receptor-activated apoptosis are associated with increased risk for development of diabetes and cardiovascular disease","volume":"26","author":"Mattisson","year":"2017","journal-title":"EBioMedicine"},{"key":"10.1016\/j.atherosclerosis.2018.01.022_bib21","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nrrheum.2012.14","article-title":"Accelerated atherosclerosis in patients with SLE\u2013mechanisms and management","volume":"8","author":"Skaggs","year":"2012","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.atherosclerosis.2018.01.022_bib22","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1146\/annurev-med-060911-090007","article-title":"Mechanisms of premature atherosclerosis in rheumatoid arthritis and lupus","volume":"64","author":"Kahlenberg","year":"2013","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.atherosclerosis.2018.01.022_bib23","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1126\/science.281.5381.1305","article-title":"Death receptors: signaling and modulation","volume":"281","author":"Ashkenazi","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.atherosclerosis.2018.01.022_bib24","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.autrev.2010.02.007","article-title":"The autoimmune lymphoproliferative syndrome: a rare disorder providing clues about normal tolerance","volume":"9","author":"Turbyville","year":"2010","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.atherosclerosis.2018.01.022_bib25","doi-asserted-by":"crossref","first-page":"4798","DOI":"10.1182\/blood-2011-04-347641","article-title":"A\u00a0survey of 90 patients with autoimmune lymphoproliferative syndrome related to TNFRSF6 mutation","volume":"118","author":"Neven","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.atherosclerosis.2018.01.022_bib26","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1590\/S1807-59322010000300014","article-title":"The role of apoptosis proteins and complement components in the etiopathogenesis of systemic lupus erythematosus","volume":"65","author":"Liphaus","year":"2010","journal-title":"Clinics"},{"key":"10.1016\/j.atherosclerosis.2018.01.022_bib27","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1080\/01913120600932677","article-title":"Review of autoimmune (lupus-like) glomerulonephritis in murine models","volume":"30","author":"Hicks","year":"2006","journal-title":"Ultrastruct. Pathol."},{"key":"10.1016\/j.atherosclerosis.2018.01.022_bib28","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1006\/clin.1994.1176","article-title":"Expression and function of Fas antigen and bcl-2 in human systemic lupus erythematosus lymphocytes","volume":"73","author":"Ohsako","year":"1994","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/j.atherosclerosis.2018.01.022_bib29","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1191\/096120301701548517","article-title":"Fas expression on peripheral blood lymphocytes in systemic lupus erythematosus (SLE): relation to lymphocyte activation and disease activity","volume":"10","author":"Bijl","year":"2001","journal-title":"Lupus"},{"key":"10.1016\/j.atherosclerosis.2018.01.022_bib30","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1126\/science.7510905","article-title":"Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule","volume":"263","author":"Cheng","year":"1994","journal-title":"Science"},{"key":"10.1016\/j.atherosclerosis.2018.01.022_bib31","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1002\/art.11264","article-title":"Elevated triglycerides and low levels of high-density lipoprotein as markers of disease activity in association with up-regulation of the tumor necrosis factor alpha\/tumor necrosis factor receptor system in systemic lupus erythematosus","volume":"48","author":"Svenungsson","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.atherosclerosis.2018.01.022_bib32","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1191\/0961203303lu412oa","article-title":"TNF-alpha: a link between hypertriglyceridaemia and inflammation in SLE patients with cardiovascular disease","volume":"12","author":"Svenungsson","year":"2003","journal-title":"Lupus"},{"key":"10.1016\/j.atherosclerosis.2018.01.022_bib33","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1097\/BOR.0000000000000083","article-title":"Beyond apoptosis in lupus","volume":"26","author":"Colonna","year":"2014","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.atherosclerosis.2018.01.022_bib34","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1038\/nm1459","article-title":"Apoptosis of vascular smooth muscle cells induces features of plaque vulnerability in atherosclerosis","volume":"12","author":"Clarke","year":"2006","journal-title":"Nat. Med."},{"key":"10.1016\/j.atherosclerosis.2018.01.022_bib35","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMra043430","article-title":"Inflammation, atherosclerosis, and coronary artery disease","volume":"352","author":"Hansson","year":"2005","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.atherosclerosis.2018.01.022_bib36","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s11883-014-0401-9","article-title":"Pathophysiology of acute coronary syndrome","volume":"16","author":"Santos-Gallego","year":"2014","journal-title":"Curr. Atherosclerosis Rep."},{"key":"10.1016\/j.atherosclerosis.2018.01.022_bib37","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1161\/01.ATV.0000148548.47755.22","article-title":"Reduced macrophage apoptosis is associated with accelerated atherosclerosis in low-density lipoprotein receptor-null mice","volume":"25","author":"Liu","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2018.01.022_bib38","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1161\/ATVBAHA.111.227140","article-title":"Apoptosis signal-regulating kinase 1 deficiency accelerates hyperlipidemia-induced atheromatous plaques via suppression of macrophage apoptosis","volume":"31","author":"Yamada","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.atherosclerosis.2018.01.022_bib39","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1161\/CIRCULATIONAHA.106.662080","article-title":"Lactadherin deficiency leads to apoptotic cell accumulation and accelerated atherosclerosis in mice","volume":"115","author":"Ait-Oufella","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2018.01.022_bib40","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1084\/jem.20031557","article-title":"Impaired clearance of apoptotic cells promotes synergy between atherogenesis and autoimmune disease","volume":"199","author":"Aprahamian","year":"2004","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.atherosclerosis.2018.01.022_bib41","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1194\/jlr.M600512-JLR200","article-title":"ApoE-\/-Fas-\/- C57BL\/6 mice: a novel murine model simultaneously exhibits lupus nephritis, atherosclerosis, and osteopenia","volume":"48","author":"Feng","year":"2007","journal-title":"J.\u00a0Lipid Res."},{"key":"10.1016\/j.atherosclerosis.2018.01.022_bib42","doi-asserted-by":"crossref","first-page":"26174","DOI":"10.1074\/jbc.271.42.26174","article-title":"Accelerated atherosclerosis in mice lacking tumor necrosis factor receptor p55","volume":"271","author":"Schreyer","year":"1996","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.atherosclerosis.2018.01.022_bib43","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1046\/j.1365-2249.1997.d01-901.x","article-title":"Serum levels of soluble Fas\/APO-1 (CD95) and its molecular structure in patients with systemic lupus erythematosus (SLE) and other autoimmune diseases","volume":"107","author":"Jodo","year":"1997","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.atherosclerosis.2018.01.022_bib44","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.imlet.2008.10.003","article-title":"A\u00a0possible role of Fas-ligand-mediated \u201creverse signaling\u201d in pathogenesis of rheumatoid arthritis and systemic lupus erythematosus","volume":"122","author":"Telegina","year":"2009","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.atherosclerosis.2018.01.022_bib45","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1093\/eurheartj\/ehn336","article-title":"High plasma concentrations of autoantibodies against native peptide 210 of apoB-100 are related to less coronary atherosclerosis and lower risk of myocardial infarction","volume":"29","author":"Sjogren","year":"2008","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.atherosclerosis.2018.01.022_bib46","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1161\/01.CIR.0000143162.56057.B5","article-title":"Recombinant human antibodies against aldehyde-modified apolipoprotein B-100 peptide sequences inhibit atherosclerosis","volume":"110","author":"Schiopu","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2018.01.022_bib47","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1016\/j.jacc.2007.07.081","article-title":"Recombinant antibodies to an oxidized low-density lipoprotein epitope induce rapid regression of atherosclerosis in apobec-1(-\/-)\/low-density lipoprotein receptor(-\/-) mice","volume":"50","author":"Schiopu","year":"2007","journal-title":"J.\u00a0Am. Coll. Cardiol."}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915018300224?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915018300224?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,21]],"date-time":"2019-01-21T13:14:53Z","timestamp":1548076493000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915018300224"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":47,"alternative-id":["S0021915018300224"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2018.01.022","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiovascular disease in systemic lupus erythematosus is associated with increased levels of biomarkers reflecting receptor-activated apoptosis","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2018.01.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}